[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2627 followers
Created: 2025-07-09 14:02:23 UTC

$CNTB Simcere Pharmaceutical, Connect Biopharma's Exclusive Licensee in China, has submitted a New Drug Application for Rademikibart to treat Atopic Dermatitis in China.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/Gva8ZxLaoAAC0Jj.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942947443987161452/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[china](/topic/china)
[$cntb](/topic/$cntb)

[Post Link](https://x.com/OzmosiHealth/status/1942947443987161452)